---
title: "Bullfrog AI Holdings, Inc. (BFRG.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BFRG.US.md"
symbol: "BFRG.US"
name: "Bullfrog AI Holdings, Inc."
industry: "Health Care Technology"
datetime: "2026-05-21T22:31:18.885Z"
locales:
  - [en](https://longbridge.com/en/quote/BFRG.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BFRG.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BFRG.US.md)
---

# Bullfrog AI Holdings, Inc. (BFRG.US)

## Company Overview

Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases.

| Item | Detail |
|------|--------|
| Industry | Health Care Technology |
| Exchange | US Market |
| Website | [www.bullfrogai.com](https://www.bullfrogai.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:18.000Z

**Overall: C (0.60)**

**Industry**: Health Care Technology

| Metric | Value |
|--------|-------|
| Industry Ranking | 25 / 47 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.00% |  |
| Net Profit YoY | 14.88% |  |
| P/B Ratio | 2.48 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 12123437.41 |  |
| Revenue | 116670.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -149.35% | E |
| Profit Margin | -5205.86% | E |
| Gross Margin | 0.00% | E |
| Revenue YoY | 0.00% | D |
| Net Profit YoY | 14.88% | C |
| Total Assets YoY | 35.56% | A |
| Net Assets YoY | 50.53% | A |
| Cash Flow Margin | 89.21% | C |
| OCF YoY | 0.00% | D |
| Turnover | 0.02 | E |
| Gearing Ratio | 11.77% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Bullfrog AI Holdings, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "0.00%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "14.88%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.48",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "12123437.41",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "116670.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-149.35%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-5205.86%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "0.00%",
          "rating": "E"
        },
        {
          "name": "Revenue YoY",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "14.88%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "35.56%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "50.53%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "89.21%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.02",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "11.77%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.00 | 28/47 | - | - | - |
| PB | 2.48 | 22/47 | 6.27 | 5.18 | 3.97 |
| PS (TTM) | 103.91 | 36/47 | 388.01 | 107.93 | 62.11 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | QHSLab, Inc. (USAQ.US) | A | A | A | A | C | A |
| 02 | Veeva Systems -CL (VEEV.US) | A | B | C | A | B | B |
| 03 | Waystar (WAY.US) | B | A | D | B | B | B |
| 04 | Doximity (DOCS.US) | A | C | C | A | B | B |
| 05 | HeartFlow (HTFL.US) | B | A | B | A | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/BFRG.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/BFRG.US/norm.md)
- [Related News](https://longbridge.com/en/quote/BFRG.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/BFRG.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**